SUBSCRIBE
SUBSCRIBE

GlaxoSmithKline

NEWS
Policy
Label Or Liability: GlaxoSmithKline Faces $3 Million Verdict Over Product It Didn’t Make
June 13, 2017
 · 
1 min read
Meet GammaDelta Therapeutics’ CEO—The Scientist Who Helped GlaxoSmithKline Launch 7 Cancer Drugs
Business
Meet GammaDelta Therapeutics’s CEO—The Scientist Who Helped GlaxoSmithKline Launch 7 Cancer Drugs
June 12, 2017
 · 
2 min read
Deals
Novartis AG Joins GlaxoSmithKline And Gets Over Its Fear Of Heights
June 5, 2017
 · 
1 min read
AstraZeneca PLC Offloads Remaining Anesthetics Portfolio in $766 Million Deal
Policy
AstraZeneca PLC Sues Former Exec After GlaxoSmithKline Poaches Him Away to Run Its Largest Business
May 16, 2017
 · 
2 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Deals
GlaxoSmithKline Apparently Prepping to Buy Out Novartis Consumer Health Joint Venture Stake for $10.3 Billion
May 15, 2017
 · 
3 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Top GlaxoSmithKline Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options
May 12, 2017
 · 
3 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Job Trends
Booming Blueprint to Expand Into Former GlaxoSmithKline Site
May 4, 2017
 · 
2 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
This is What Shaved $3 Billion Off of GlaxoSmithKline’s Market Cap Last Month
May 4, 2017
 · 
2 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Business
GlaxoSmithKline Injects $139 Million in Maryland Expansion
May 1, 2017
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Deals
GlaxoSmithKline Drops Iconic Brands for €1.2 Billion
September 6, 2013
 · 
1 min read
Drug Development
GlaxoSmithKline’s MAGE-A3 Does Not Meet First Co-Primary Endpoint in Phase 3 Trial
September 5, 2013
 · 
8 min read
Policy
China Police: Crimes Were Organized by GlaxoSmithKline, Not Individual Staffers
September 3, 2013
 · 
1 min read
Drug Development
GlaxoSmithKline’s Crohn’s Disease Drug Fails Phase 3 Trial, ChemoCentryx, Inc. Stock Falls -32.12% on Friday at Market Close (August 23, 2013)
August 23, 2013
 · 
7 min read
GlaxoSmithKline Bribery Scandal: British Risk Consultant Held in China Arrested
August 21, 2013
 · 
1 min read
FDA
Additional GlaxoSmithKline Quadrivalent Intramuscular Influenza Vaccine Approved by FDA
August 16, 2013
 · 
7 min read
Race to Publish May Have Been GlaxoSmithKline’s Downfall
August 8, 2013
 · 
1 min read
GlaxoSmithKline Plugs Into Bioelectronics With $50 Million Venture Fund
August 8, 2013
 · 
1 min read
Pharm Country
GlaxoSmithKline Receives FDA Approval to Ship Four-Strain (Quadrivalent) Influenza Vaccine to Healthcare Providers
August 5, 2013
 · 
6 min read
Policy
GlaxoSmithKline Diabetes Drug Faces U.S. Approval Delay
August 2, 2013
 · 
1 min read
Load More